论文部分内容阅读
实体肿瘤的抗血管新生基因治疗就是将外源基因靶向血管内皮细胞 ,直接作用于肿瘤细胞生长所依赖的新生血管 ,而达到治愈肿瘤的目的。同时也最大程度地减少了抗血管新生物质的全身毒副作用。本文就实体肿瘤的抗血管新生基因治疗现状作一综述。
The anti-angiogenic gene therapy for solid tumors is to target foreign genes to vascular endothelial cells and directly act on neovasculatures on which tumor cells depend, thus achieving the goal of healing tumors. At the same time, the systemic side effects of antiangiogenic substances are also minimized. This article reviews the status of anti-angiogenesis gene therapy in solid tumors.